Table of contents
May 2007 Vol 8 No 5
From the editors
p321 | doi:10.1038/nrg2109
Research Highlights
Epigenetics: Transcriptional memory remodelled
p323 | doi:10.1038/nrg2110
Evolution: Colour vision for mice
p324 | doi:10.1038/nrg2106
In the news
Glowing gnats Malaria's downfall
p324 | doi:10.1038/nrg2107
Technology: Driving out insect-borne pathogens
p324 | doi:10.1038/nrg2112
In brief
Human disease | Epigenetics | Genomics | Transcriptomics
p325 | doi:10.1038/nrg2117
Circadian genetics: Setting the pace: three's company
p326 | doi:10.1038/nrg2115
Cancer genetics: Micro enhancement
p326 | doi:10.1038/nrg2116
In brief
Technology | Sociogenomics | RNA world | Human disease
p326 | doi:10.1038/nrg2118
RNA world: Dicer in the mammalian female germ line
p327 | doi:10.1038/nrg2120
Genome evolution: How old are Hox genes?
p328 | doi:10.1038/nrg2114
Evolution: Duplicates provide only limited cover
p328 | doi:10.1038/nrg2119
Webwatch
Camera takes its shot
p329 | doi:10.1038/nrg2104
Gene expression: A not-so-passive spliceosome
p329 | doi:10.1038/nrg2113
AN INTERVIEW WITH...
Janet Rossant
p330 | doi:10.1038/nrg2108
Reviews
Biology by numbers: mathematical modelling in developmental biology
Claire J. Tomlin & Jeffrey D. Axelrod
p331 | doi:10.1038/nrg2098
One promising way of attempting to understand the complexity of biological processes is to model them mathematically. Such models can help predict the wider biological effects of local interactions and are now producing testable hypotheses about the workings of developmental systems.
Genetic determinants of cancer metastasis
Don X. Nguyen & Joan Massagué
p341 | doi:10.1038/nrg2101
Genome-wide technologies, functional experimentation in model systems and clinical validation are beginning to identify genetic and epigenetic alterations that underlie metastatic disease. These genetic determinants are distinct from those that mediate malignant transformation and can be classified into metastasis initiation, metastasis progression and metastasis virulence genes.
Animal models of human disease: zebrafish swim into view
Graham J. Lieschke & Peter D. Currie
p353 | doi:10.1038/nrg2091
Animal models are crucial for understanding the pathogenesis of human disease and provide a system in which to develop and test new therapies. The zebrafish offers unique advantages over other vertebrates and is therefore rapidly emerging as a model organism for a wide range of human diseases, both genetic and acquired, and for therapeutic drug discovery and development.
Gene function in mouse embryogenesis: get set for gastrulation
Patrick P. L. Tam & David A. F. Loebel
p368 | doi:10.1038/nrg2084
Successful gastrulation depends on a complex pattern of signalling and gene expression in the early embryo. Uniquely in mammals, this involves both embryonic and extraembryonic tissue. This Review examines how lineages are specified and cell movements are co-ordinated in the early mouse embryo.
Hybrid necrosis: autoimmunity as a potential gene-flow barrier in plant species
Kirsten Bomblies & Detlef Weigel
p382 | doi:10.1038/nrg2082
Reduction in gene flow between varieties is part of the process of speciation. One underappreciated reason for such a reduction is hybrid necrosis — when the hybrid offspring have phenotypes that resemble the results of pathogen attack and environmental stress.
Perspective
Essay
The origin of eukaryotes: a reappraisal
Christian de Duve
p395 | doi:10.1038/nrg2071
Did the main features of eukaryotes, including endocytosis, develop before the adoption of endosymbionts? Or was their evolution triggered by an interaction between two typical prokaryotic cells, one of which became the host and the other the endosymbiont? Christian de Duve re-examines this important question in the light of cell-biological and phylogenetic data.
Correspondence
Correspondence: Loss-of-function genetic diseases and the concept of pharmaceutical targets
L. Ségalat
| doi:10.1038/nrg1828-c1
Author Reply: Loss-of-function genetic diseases and the concept of pharmaceutical targets
Ryan R. Brinkmann, Marie-Pierre Dubé, Guy A. Rouleau, Andrew C. Orr & Mark E. Samuels
| doi:10.1038/nrg1828-c2


